Using data from the Million Veteran Program, VA researchers found that a blood pressure condition called resistant hypertension can increase the risk of cardiovascular problems and kidney failure.
Agricultural organization aims to reintegrate Vets into society, prevent suicide
The University of New Mexico and the New Mexico VA Health Care System will use a $3.1 million federal grant to study a new approach to use electrical stimulation as therapy for mild traumatic brain injuries.
P.I.: Sam Lee, Ph.D., M.D.
P.I.: Sara Cichowski, M.D.
P.I.: Karen Cusack, Ph.D.
Demonstrating the Efficacy of Group Prolonged Exposure Treatment of PTSD in OEF/OIF/ OND Male Veterans
P.I. Janet Kathreen C’de Baca, Ph.D.
PROMINENT Pemafibrate to Reduce cardiovascular OutcoMes by reducing triglycerides IN patiENts with diabetes
P.I.: Michelle Ratliffe, MD Synopsis- This is a research study to find out if K-877 (also called pemafibrate), the study drug, compared to placebo (a treatment which looks like the medicine but contains no active pemafibrate), lowers cardiovascular (CV) complications (also referred to as “events”), such as heart attack, stroke, and death from these conditions, [...]
Influenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated heart failure (INVESTED)
P.I.: Michelle Ratliffe, MD Synopsis- The purpose of this study is to see if a high-dose influenza (“flu”) vaccine is able to safely reduce heart or lung-related problems compared to the standard-dose flu vaccine. Both the high dose and standard dose flu vaccines called Fluzone® are manufactured by Sanofi Pasteur.